These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 23253254)
61. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. Hewes JC; Dighe S; Morris RW; Hutchins RR; Bhattacharya S; Davidson BR World J Surg; 2007 Feb; 31(2):353-64; discussion 365-6. PubMed ID: 17219289 [TBL] [Abstract][Full Text] [Related]
62. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725 [TBL] [Abstract][Full Text] [Related]
63. Timing of Perioperative Chemotherapy Does Not Influence Long-Term Outcome of Patients Undergoing Combined Laparoscopic Colorectal and Liver Resection in Selected Upfront Resectable Synchronous Liver Metastases. Ratti F; Fuks D; Cipriani F; Gayet B; Aldrighetti L World J Surg; 2019 Dec; 43(12):3110-3119. PubMed ID: 31451846 [TBL] [Abstract][Full Text] [Related]
64. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. Allen PJ; Kemeny N; Jarnagin W; DeMatteo R; Blumgart L; Fong Y J Gastrointest Surg; 2003 Jan; 7(1):109-117. PubMed ID: 12559192 [TBL] [Abstract][Full Text] [Related]
65. Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma. Lorenz M; Müller HH; Staib-Sebler E; Vetter G; Gog C; Petrowsky H; Köhne CH Langenbecks Arch Surg; 1999 Aug; 384(4):328-38. PubMed ID: 10473852 [TBL] [Abstract][Full Text] [Related]
66. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Okuno M; Hatano E; Kasai Y; Nishio T; Seo S; Taura K; Yasuchika K; Nitta T; Mori A; Okajima H; Kaido T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S Surg Today; 2016 Jun; 46(6):721-8. PubMed ID: 26315324 [TBL] [Abstract][Full Text] [Related]
67. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Chua TC; Saxena A; Liauw W; Kokandi A; Morris DL Ann Surg Oncol; 2010 Feb; 17(2):492-501. PubMed ID: 19856028 [TBL] [Abstract][Full Text] [Related]
71. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. Stift J; Graf A; Schwarz C; Tamandl D; Starlinger P; Herac M; Beer A; Wrba F; Bodingbauer M; Kaczirek K; Stremitzer S Eur J Surg Oncol; 2018 Jan; 44(1):139-147. PubMed ID: 29203074 [TBL] [Abstract][Full Text] [Related]
72. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. Zhu D; Zhong Y; Wei Y; Ye L; Lin Q; Ren L; Ye Q; Liu T; Xu J; Qin X PLoS One; 2014; 9(1):e86543. PubMed ID: 24466143 [TBL] [Abstract][Full Text] [Related]
73. 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Mentha G; Roth AD; Terraz S; Giostra E; Gervaz P; Andres A; Morel P; Rubbia-Brandt L; Majno PE Dig Surg; 2008; 25(6):430-5. PubMed ID: 19212115 [TBL] [Abstract][Full Text] [Related]
74. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis. Liu W; Zhou JG; Sun Y; Zhang L; Xing BC Oncotarget; 2016 Jun; 7(24):37277-37287. PubMed ID: 27074564 [TBL] [Abstract][Full Text] [Related]
75. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy]. Lordick F; Knödler M; Hacker U; Bartels M Chirurg; 2014 Jan; 85(1):11-6. PubMed ID: 24292192 [TBL] [Abstract][Full Text] [Related]
76. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro primary surgery]. Heinrich S; Lang H Chirurg; 2014 Jan; 85(1):17-23. PubMed ID: 24337153 [TBL] [Abstract][Full Text] [Related]
77. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer? Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329 [TBL] [Abstract][Full Text] [Related]
78. [Multimodality therapy of colorectal cancer]. Hacker U; Hallek M; Kubicka S Internist (Berl); 2010 Nov; 51(11):1366-73. PubMed ID: 20967408 [TBL] [Abstract][Full Text] [Related]
79. The Role of Preoperative Chemotherapy in the Management of Synchronous Resectable Colorectal Liver Metastases: A Meta-Analysis. Tepelenis K; Pappas-Gogos G; Ntellas P; Tsimogiannis K; Dadouli K; Mauri D; Glantzounis GK Curr Oncol; 2023 Apr; 30(5):4499-4511. PubMed ID: 37232798 [TBL] [Abstract][Full Text] [Related]
80. Surgical dilemmas in the management of colorectal liver metastases: The role of timing. Dimitroulis D; Kouraklis G World J Gastroenterol; 2016 Jun; 22(21):4963-5. PubMed ID: 27275088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]